1-(Benzo[d]oxazol-2-yl)piperidine-4-carboxylic acid

Catalog No. :
ACWEOP018
CAS No. :
181811-46-1
Molecular Formula :
C13H14N2O3
Molecular Weight :
246.27

IUPAC Name:1-(benzo[d]oxazol-2-yl)piperidine-4-carboxylic acid

1-(Benzo[d]oxazol-2-yl)piperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$75.00Login to see priceInquiryInquiry
250mg95%$149.00Login to see priceInquiryInquiry
1g95%$372.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Benzo[d]oxazol-2-yl)piperidine-4-carboxylic acid
IUPAC Name1-(benzo[d]oxazol-2-yl)piperidine-4-carboxylic acid
MDL No.MFCD03830245
Molecular FormulaC13H14N2O3
Molecular Weight246.27
SMILESO=C(C1CCN(C2=NC3=CC=CC=C3O2)CC1)O
InChI KeyOWLMBHUAWNJFSB-UHFFFAOYSA-N
SynonymBUTTPARK 120\07-03;1-(1,3-BENZOXAZOL-2-YL)PIPERIDINE-4-CARBOXYLIC ACID;1-Benzooxazol-2-yl-piperidine-4-carboxylic acid;1-(2-benzoxazolyl)-4-Piperidinecarboxylic acid;4-Piperidinecarboxylic acid, 1-(2-benzoxazolyl)-;1-(1,3-Benzoxazol-2-yl)piperidine-4-carboxylic acid - [B92461];1-(2-Benzo[d]oxazolyl)-4-piperidinecarboxylic acid
CAS No.181811-46-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWEOP018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWEOP018 route product structure diagram
    ACWEOP018181811-46-1
Inquiry

2. ACWEOP018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWEOP018 route product structure diagram
    ACWEOP018181811-46-1
Inquiry

Comments (0)